Predictions
Wirecard AG
Start price
Target price
Perf. (%)
€1.60
20.07.20
20.07.20
-
04.11.21
04.11.21
-88.74%
05.11.21
05.11.21
Risky Investment
High risks for its business
High risks in the balance sheet
Growths much slower than the competition
Wirecard AG
Start price
Target price
Perf. (%)
€1.60
20.07.20
20.07.20
€1.00
14.08.20
14.08.20
-11.99%
14.08.20
14.08.20
Risky Investment
Deficits in Management
Very bad culture
High risks for its business
Noble Corporation
Start price
Target price
Perf. (%)
€0.25
19.07.20
19.07.20
€28.00
04.11.21
04.11.21
578.42%
05.11.21
05.11.21
Mercedes-Benz Group AG
Start price
Target price
Perf. (%)
€39.51
17.07.20
17.07.20
€88.00
04.11.21
04.11.21
118.83%
05.11.21
05.11.21
Copper Mountain Mining
Start price
Target price
Perf. (%)
€0.47
17.07.20
17.07.20
-
04.11.21
04.11.21
432.25%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Future proof or reliable business model
Revenue growth >5% per year expected
Tele2 Ab -b-(21358576)
Start price
Target price
Perf. (%)
€12.33
17.07.20
17.07.20
€20.00
04.11.21
04.11.21
0.57%
05.11.21
05.11.21
T-Mobile US Inc.
Start price
Target price
Perf. (%)
€91.98
17.07.20
17.07.20
€120.00
04.11.21
04.11.21
15.61%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Engie S.A.
Start price
Target price
Perf. (%)
€11.20
17.07.20
17.07.20
€12.60
04.11.21
04.11.21
12.84%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Navya S.a.
Start price
Target price
Perf. (%)
€1.26
17.07.20
17.07.20
€2.50
04.11.21
04.11.21
39.30%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Lannett Co. Inc.
Start price
Target price
Perf. (%)
€21.89
16.07.20
16.07.20
€120.00
04.11.21
04.11.21
-63.45%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Revenue growth > 30% per year expected
High Investments for future growth
Heidelberger Druckmaschinen AG
Start price
Target price
Perf. (%)
€0.61
16.07.20
16.07.20
-
04.11.21
04.11.21
314.83%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Capable Management
Future proof or reliable business model
Brockhaus Capital Mgmt AG
Start price
Target price
Perf. (%)
€34.65
16.07.20
16.07.20
-
04.11.21
04.11.21
-33.33%
05.11.21
05.11.21
Pfizer Inc.
Start price
Target price
Perf. (%)
€29.70
16.07.20
16.07.20
€33.21
25.08.20
25.08.20
4.15%
25.08.20
25.08.20
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
BYD Co. Ltd
Start price
Target price
Perf. (%)
€8.86
15.07.20
15.07.20
€28.00
04.11.21
04.11.21
209.03%
20.08.21
20.08.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Undervalued
Tilray Inc
Start price
Target price
Perf. (%)
€6.71
15.07.20
15.07.20
-
04.11.21
04.11.21
40.65%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Standard Investments for future growth
Very capable Management
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€3.18
15.07.20
15.07.20
-
01.08.20
01.08.20
-36.48%
01.08.20
01.08.20
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€3.62
14.07.20
14.07.20
-
15.07.20
15.07.20
-12.15%
15.07.20
15.07.20
Aphria Inc.
Start price
Target price
Perf. (%)
€4.27
14.07.20
14.07.20
€5.85
05.08.20
05.08.20
-5.09%
05.08.20
05.08.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Proshs Ultrapro Short Qqq New
Start price
Target price
Perf. (%)
€6.24
14.07.20
14.07.20
-
04.11.21
04.11.21
-26.93%
05.11.21
05.11.21
Risky Investment
Gazprom ADR
Start price
Target price
Perf. (%)
€4.90
13.07.20
13.07.20
-
04.11.21
04.11.21
0.43%
05.02.21
05.02.21
Could be worthwhile Investment >10% per year
Very high dividend yield expected
positive Cash Flow expected
Good rating
BioNTech SE ADR
Start price
Target price
Perf. (%)
€67.74
13.07.20
13.07.20
€250.00
04.11.21
04.11.21
254.74%
05.11.21
05.11.21
EBIT growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
Higher risks for its business